Infectious Diseases News and Research

RSS

Two clever human antibodies can target Ebola and Sudan virus

Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

Lateral flow assays: The possibilities beyond COVID-19

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences company) about the possibilities lateral flow assays offer in the post-covid healthscape.

From nanoComposix 17 Mar 2022

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

Income loss was a strong predictor of menstrual product insecurity across the U.S. during COVID-19, and populations with lower incomes and the lowest educational attainment were most vulnerable, according to a new study conducted by Columbia University Mailman School of Public Health in partnership with the CUNY School of Public Health.

16 Mar 2022

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

A Saint Louis University School of Medicine scientist and SLUCare physician has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) to study Short Bowel Syndrome (SBS).

16 Mar 2022

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

A small preliminary study from Northwestern Medicine has shown that a blood test may identify risk of stillbirth and placentitis in pregnant individuals who have had COVID-19.

16 Mar 2022

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system.

16 Mar 2022

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

Scientists from Nanyang Technological University, Singapore have developed a novel method of delivering drugs into human cells using large biological molecules, by first encasing them in a protein-based microdroplet.

16 Mar 2022

Discovery of key brain pathway offers potential new drug target for treating anxiety

A new target in the brain which underpins the eliciting of anxiety and fear behaviors such as 'freezing' has been identified by neuroscientists.

15 Mar 2022

New way to deliver potential HIV vaccine using mRNA technology

Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.

15 Mar 2022

Researchers identify a potential new test for early diagnosis of Lyme disease

For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.

15 Mar 2022

High doses of antibiotic may safely and effectively treat TB meningitis

A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form of tuberculosis that affects the brain, potentially improving survival rates for patients and decreasing the likelihood of lasting adverse effects of the disease.

15 Mar 2022

Moderate hyperglycemia associated with poor COVID-19 prognosis

Scientists have revealed that non-diabetic patients with moderate hyperglycemia are more likely to develop severe and fatal COVID-19 than diabetic patients.

15 Mar 2022

Study raises hopes for effective treatment of infant B acute lymphoblastic leukemia

New research has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children.

14 Mar 2022

Study: Almost half of over-35s not confident in recognizing cardiac risk during exercise

A new study assessing the knowledge and confidence in recognizing cardiac symptoms has found that almost half of over-35s were not confident in their ability to recognize symptoms of impending cardiac risk – such as a heart attack or sudden cardiac death – while participating in strenuous exercise.

14 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

UC San Diego receives $38 million USAID grant to address gender equity and health issues

The U.S. Agency for International Development has funded a $38 million, five-year project led by the Center on Gender Equity and Health at University of California San Diego School of Medicine and Herbert Wertheim School of Public Health and Human Longevity Science.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

Can wearables transform the future of healthcare?

In partnership with SLAS 2022, we spoke to Professor Michael Snyder about his latest research that investigates wearables and their future within healthcare.

From Society for Laboratory Automation and Screening (SLAS) 14 Mar 2022

Infectious Diseases News and Research

Two clever human antibodies can target Ebola and Sudan virus

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Lateral flow assays: The possibilities beyond COVID-19

Study clarifies sex-based burdens during the pandemic, raises awareness for menstrual equity

SLU physician-scientist receives NIH funding for Short Bowel Syndrome research

Blood test may identify risk of stillbirth and placentitis in pregnant patients with COVID-19

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Sneaking large drug-carrying biological molecules into cells using a novel drug delivery system

Discovery of key brain pathway offers potential new drug target for treating anxiety

New way to deliver potential HIV vaccine using mRNA technology

Researchers identify a potential new test for early diagnosis of Lyme disease

High doses of antibiotic may safely and effectively treat TB meningitis

Moderate hyperglycemia associated with poor COVID-19 prognosis

Study raises hopes for effective treatment of infant B acute lymphoblastic leukemia

Study: Almost half of over-35s not confident in recognizing cardiac risk during exercise

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

UC San Diego receives $38 million USAID grant to address gender equity and health issues

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

Can wearables transform the future of healthcare?

Industry Focus: Infectious Diseases eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News